CareDx - CDNA Enterprise Value-to-Revenue Multiple

Official company branding of caredx.com (CDNA)

CareDx, Inc (CDNA) is implementing autonomous DNA analysis systems, which is reflected dynamically on GURU.Markets via the EV/Sales market multiple, currently standing at 7151.99. Tests for various organs ensure business stability, while the asset's defensive qualities are confirmed by demand that remains independent of economic cycles, making the company resilient to market volatility.

CDNA: caredx.com Company Value to Revenue 11/23/2025 - 11/20/2026

CareDx Inc - analytical breakdowns and key metrics (CDNA)

Initial company analysis:CareDx Health, CDNA
Product sample of CareDx, Inc.

Investors assess asset quality by comparing the market value of a business with its actual earnings. This metric excludes the impact of debt load, highlighting the net efficiency of revenue generation. By analyzing the current price-to-sales ratio of CareDx, Inc (CDNA), one can determine the level of market optimism or the risk of overpayment. An increase in this indicator confirms the market's belief in the technological superiority of CareDx, Inc (CDNA). This is critical for a leader in precision monitoring investing in innovative DNA analysis.

Competitor analysis for CareDx, Inc

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Business Value to Revenue MRVI (Maravai)|FLGT: EV/Sales Multiple|LAB (Standard BioTools Inc.) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Cytek Biosciences Inc|Enterprise Value-to-Revenue Multiple OraSure OSUR|Company Value to Revenue XGN (Exagen Diagnostics)|Total Company Value-to-Revenue Ratio MDxHealth Inc.|Enterprise Value-to-Revenue Ratio Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Enterprise Value-to-Revenue Multiple|Insight Molecular Diagnostics Inc - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple trinitybiotech.com|PRPH (ProPhase) - Company Value to Revenue|Company Value to Revenue Ratio AIMD|Company Value to Revenue CODX|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue